/viestories/media/media_files/2025/07/02/astra-share-price-37-2025-07-02-10-54-07.jpg)
AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company that builds and sells prescription medicines through innovative methods. Its core therapeutic areas include cancer, CVRM, immunology, respiratory, and rare disorders. With a strong focus on research and development, it has emerged as a global healthcare solutions provider.
Currently, AstraZeneca Ltd.'s share price is approximately 8,981.50 INR. In the last 52 weeks, the highest price was around 10,691.00 INR, and the lowest price was 6,220.00 INR. Let's see the AstraZeneca Ltd. share price target for 2025 and 2026 to 2030.
Table of Contents
AstraZeneca Ltd Share Price Chart
Here's the AstraZeneca Ltd. share price chart over the last 5 years. The stock started at around Rs 3,513-3,514 and steadily climbed to the Rs 10,509-10,510 range, with the usual market fluctuations along the way.
/filters:format(webp)/viestories/media/media_files/2025/07/02/astrazeneca-pharma-2025-07-02-10-52-16.png)
ASTRAZEN Share Price Target 2025
In 2025, the share price is expected to reach Rs.7,694.94, and by the end of the month, it is expected to reach Rs. 9,785.10.
| Month (2025) | Target |
|---|---|
| March | ₹7,694.94 |
| April | ₹8,410.70 |
| May | ₹8,550.36 |
| June | ₹9,021.71 |
| July | ₹9,213.74 |
| August | ₹9,318.49 |
| September | ₹9,353.40 |
| October | ₹9,807.30 |
| November | ₹9,829.50 |
| December | ₹9,785.10 |
ASTRAZEN Share Price Target 2026
According to the technical data, the minimum share price target is expected to reach Rs. 9,585.30, and the maximum share price is expected to reach Rs. 12,443.00.
| Month (2026) | Target |
|---|---|
| January | ₹9,585.30 |
| February | ₹10,539.88 |
| March | ₹10,784.07 |
| April | ₹10,695.28 |
| May | ₹10,872.87 |
| June | ₹11,472.26 |
| July | ₹11,716.45 |
| August | ₹11,849.65 |
| September | ₹11,894.04 |
| October | ₹12,471.23 |
| November | ₹12,499.46 |
| December | ₹12,443.00 |
/viestories/media/media_files/2025/06/30/f-and-b-magazine720x90-2025-06-30-11-17-51.jpg)
ASTRAZEN Share Price Target 2027
According to the technical data, the minimum share price target is expected to reach Rs. 12,188.93, and the maximum share price is expected to reach Rs. 15,822.86.
| Month (2027) | Target |
|---|---|
| January | ₹12,188.93 |
| February | ₹13,402.80 |
| March | ₹13,713.32 |
| April | ₹13,600.40 |
| May | ₹13,826.24 |
| June | ₹14,588.43 |
| July | ₹14,898.96 |
| August | ₹15,068.33 |
| September | ₹15,124.79 |
| October | ₹15,858.76 |
| November | ₹15,894.65 |
| December | ₹15,822.86 |
ASTRAZEN Share Price Target 2028
According to the technical data, the minimum share price target is expected to reach Rs.15,499.78, and the maximum share price is expected to reach Rs.20,120.78.
| Month (2028) | Target |
|---|---|
| January | ₹15,499.78 |
| February | ₹17,043.36 |
| March | ₹17,438.23 |
| April | ₹17,294.65 |
| May | ₹17,581.82 |
| June | ₹18,551.05 |
| July | ₹18,945.92 |
| August | ₹19,161.30 |
| September | ₹19,233.10 |
| October | ₹20,166.43 |
| November | ₹20,212.07 |
| December | ₹20,120.78 |
ASTRAZEN Share Price Target 2029
According to the technical data, the minimum share price target is expected to reach Rs. 19,709.95, and the maximum share price is expected to reach Rs. 25,586.13.
| Month (2029) | Target |
|---|---|
| January | ₹19,709.95 |
| February | ₹21,672.81 |
| March | ₹22,174.94 |
| April | ₹21,992.34 |
| May | ₹22,357.53 |
| June | ₹23,590.02 |
| July | ₹24,092.15 |
| August | ₹24,366.04 |
| September | ₹24,457.33 |
| October | ₹25,644.18 |
| November | ₹25,702.23 |
| December | ₹25,586.13 |
ASTRAZEN Share Price Target 2030
According to the technical data, the minimum share price target is expected to reach Rs.25,063.71, and the maximum share price is expected to reach Rs.32,536.02.
| Month (2030) | Target |
|---|---|
| January | ₹25,063.71 |
| February | ₹27,559.74 |
| March | ₹28,198.25 |
| April | ₹27,966.07 |
| May | ₹28,430.44 |
| June | ₹29,997.72 |
| July | ₹30,636.24 |
| August | ₹30,984.52 |
| September | ₹31,100.61 |
| October | ₹32,609.84 |
| November | ₹32,683.65 |
| December | ₹32,536.02 |
Conclusion: AstraZeneca Ltd share price
AstraZeneca is considered an investment due to its strong market position, robust drug pipeline, and ambition for development. It focuses on many rare diseases and worldwide expansion, which shows its long-term wealth development, despite some challenges and hurdles. Its innovation and market growth show it will give the best result.
FAQ
Reference:
For AstraZeneca Share more detailed information, visit trusted source Yahoo Finance https://finance.yahoo.com/quote/ASTRAZEN.NS/
Disclaimer:
- The information is based on our understanding of the stock's historical performance.
- Stock market predictions are unpredictable and can change, so expert advice is strongly recommended before investing.
- The values provided are based on predictions and may not be accurate; we recommend verifying the information with other sources.
- For further inquiries about the stock market, please contact us via email.
Explore more:
